These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8342123)

  • 1. Use of gene therapy to induce human-mouse xenogeneic chimerism.
    Fox IJ; Athan E; Fisher J; Baxter T; Podda S; Richardson C
    Surgery; 1993 Aug; 114(2):174-81; discussion 181-2. PubMed ID: 8342123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen.
    Schumacher IK; Newberg MH; Jackson JD; Hammel JM; Rubocki RJ; Engelhard VH; Fox IJ
    Transplantation; 1996 Sep; 62(6):831-6. PubMed ID: 8824485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gene therapy to induce antigen-specific immunologic unresponsiveness to class I xenogeneic major histocompatibility complex antigens.
    Schumacher I; Jeevarathnam S; Rubbocki R; Fox IJ
    Transplant Proc; 1995 Feb; 27(1):313-4. PubMed ID: 7879017
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo.
    Fry JW; Morris PJ; Wood KJ
    Gene Ther; 2002 Feb; 9(3):220-6. PubMed ID: 11859426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance by selective in vivo expansion of foreign major histocompatibility complex-transduced autologous bone marrow.
    Zhang JL; Cai J; Walls S; Jackson JD; Kuszynski CA; Zhao Y; Pawliuk R; Leboulch P; Fox IJ
    Transplantation; 2005 Aug; 80(3):362-9. PubMed ID: 16082332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
    Tian C; Bagley J; Kaye J; Iacomini J
    J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
    Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
    Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
    Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
    Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.